Computational Chemistry and Molecular Modeling of Reversible Mao Inhibitors

dc.authorscopusid 6506158277
dc.authorscopusid 24463261600
dc.contributor.author Yelekçi, K.
dc.contributor.author Yelekçi, Kemal
dc.contributor.author Erdem, S.S.
dc.contributor.other Molecular Biology and Genetics
dc.date.accessioned 2023-10-19T15:05:15Z
dc.date.available 2023-10-19T15:05:15Z
dc.date.issued 2023
dc.department-temp Yelekçi, K., Department of Bioinformatics and Genetics, Faculty of Engineering and Natural Sciences, Kadir Has University, Istanbul, Turkey; Erdem, S.S., Department of Chemistry, Faculty of Arts and Sciences, Marmara University, Istanbul, Turkey en_US
dc.description.abstract Proper elucidation of drug-target interaction is one of the most significant steps at the early stages of the drug development research. Computer-aided drug design tools have substantial contribution to this stage. In this chapter, we specifically concentrate on the computational methods widely used to develop reversible inhibitors for monoamine oxidase (MAO) isozymes. In this context, current computational techniques in identifying the best drug candidates showing high potency are discussed. The protocols of structure-based drug design methodologies, namely, molecular docking, in silico screening, and molecular dynamics simulations, are presented. Employing case studies of safinamide binding to MAO B, we demonstrate how to use AutoDock 4.2.6 and NAMD software packages. © 2023, The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature. en_US
dc.identifier.citationcount 4
dc.identifier.doi 10.1007/978-1-0716-2643-6_17 en_US
dc.identifier.endpage 252 en_US
dc.identifier.issn 1064-3745
dc.identifier.pmid 36169867 en_US
dc.identifier.scopus 2-s2.0-85139376065 en_US
dc.identifier.startpage 221 en_US
dc.identifier.uri https://doi.org/10.1007/978-1-0716-2643-6_17
dc.identifier.uri https://hdl.handle.net/20.500.12469/4776
dc.identifier.volume 2558 en_US
dc.khas 20231019-Scopus en_US
dc.language.iso en en_US
dc.publisher Humana Press Inc. en_US
dc.relation.ispartof Methods in Molecular Biology en_US
dc.relation.publicationcategory Kitap Bölümü - Uluslararası en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.scopus.citedbyCount 4
dc.subject Docking en_US
dc.subject Molecular dynamics en_US
dc.subject Monoamine oxidase en_US
dc.subject Virtual screening en_US
dc.subject monoamine oxidase inhibitor en_US
dc.subject safinamide en_US
dc.subject selegiline en_US
dc.subject amine oxidase (flavin containing) en_US
dc.subject isoenzyme en_US
dc.subject monoamine oxidase inhibitor en_US
dc.subject cheminformatics en_US
dc.subject controlled study en_US
dc.subject drug protein binding en_US
dc.subject drug screening en_US
dc.subject molecular docking en_US
dc.subject molecular model en_US
dc.subject chemistry en_US
dc.subject metabolism en_US
dc.subject structure activity relation en_US
dc.subject Computational Chemistry en_US
dc.subject Isoenzymes en_US
dc.subject Molecular Docking Simulation en_US
dc.subject Monoamine Oxidase en_US
dc.subject Monoamine Oxidase Inhibitors en_US
dc.subject Structure-Activity Relationship en_US
dc.title Computational Chemistry and Molecular Modeling of Reversible Mao Inhibitors en_US
dc.type Book Part en_US
dspace.entity.type Publication
relation.isAuthorOfPublication 9407938e-3d31-453b-9199-aaa8280a66c5
relation.isAuthorOfPublication.latestForDiscovery 9407938e-3d31-453b-9199-aaa8280a66c5
relation.isOrgUnitOfPublication 71ce8622-7449-4a6a-8fad-44d881416546
relation.isOrgUnitOfPublication.latestForDiscovery 71ce8622-7449-4a6a-8fad-44d881416546

Files